On Tuesday, in the midst of a first-quarter sales miss for Biogen BIIB, +0.73% …
KOSPI index rises, foreigners sell * Korean won inches up versus U.S. dollar * South Korea bond yields down SEOUL, May 18 Round-up of South Korean financial markets: ** South Korea's KOSPI stock index and the Korean won both …
Case in point: Spreading $10,000 evenly among shares of Biogen Inc. (NASDAQ:BIIB), Celgene Corporation (NASDAQ ... treatments to thank for the …
Biogen (BIIB) director Alexander J. Denner bought 48,000 shares on April 25 for $13 million, or $269.91 each. Denner, who has been on the board of the biotech since …
The patented option-trade picking algorithms that power MarketIntelligenceCenter.com's Artificial Intelligence Center are highlighting two trades on Biogen Idec (BIIB) today after it ... as long as the stock closes above $280 at expiration.
The bad news is that Biogen Inc (NASDAQ:BIIB) stock is down 32% since the end of January. The good news is that the shares are poised to bounce back from this selloff. What’s more, you can profit handsomely from the rebound. After …
Ms. Susan H. Alexander, Esq., is Executive Vice President, Chief Legal, Corporate Services and Secretary of the Company. Prior to that, from December 2011 to March 2017, Ms. Alexander served as our Executive Vice President, …
Mr. Jeffrey D. Capello is Chief Financial Officer, Executive Vice President of the Company. Prior to that, Mr. Capello served as the Chief Financial Officer of Beacon Health Options, Inc., a behavioral health company, with responsibility for …